Impact of primary series vaccination on clinical presentations and outcomes among critically ill patients with coronavirus disease 2019 (COVID-19) in Taiwan during the Omicron era.
Abstract
Background
Among critically ill patients infected by the Omicron variant of coronavirus disease 2019 (COVID-19), the impact of COVID-19 vaccination on outcomes varied.
Methods
A retrospective cohort study including adults with active COVID-19 admitted to dedicated intensive care units was conducted at a medical center in southern Taiwan between April 27, 2022 and Apr 26, 2023. Baseline characteristics, clinical presentations, management, and outcomes were compared between patients with and without primary series vaccination (PSV). Logistic regression and propensity score matching were used to identify factors associated with clinical outcomes.
Results
Among 397 critically ill patients with COVID-19, 194 (48.9%) had not completed PSV. Patients without PSV more often presented with pneumonia (67.5% vs. 46.3%, p < 0.001), acute respiratory distress syndrome (53.1% vs. 30.1%, p < 0.001), had a higher in-hospital mortality rate (34.5% vs. 24.6%, p = 0.0305), longer hospital stays (median 21.5 days vs. 18.0 days, p = 0.018), and fewer ventilator-free days at 28 days (median 18 days vs. 24 days, p = 0.004). In the multivariable logistic regression analysis, factors associated with in-hospital mortality included solid organ malignancies, higher SOFA score, and lack of PSV. The association of PSV and lower in-hospital mortality remained significant in a propensity score-matched cohort (odds ratio 0.46, 95% confidence interval 0.26-0.81, p = 0.008).
Conclusions
Among critically ill patients infected by SARS-CoV-2 Omicron variant, prior receipt of PSV was associated with a favorable outcome, as evidenced by a lower in-hospital mortality rate and more ventilator-free days at 28 days.